Objective: An elevated plasma homocysteine (Hcy) level is considered an independent risk factor for atherosclerosis. However, the mechanisms by which hyperhomocysteinemia induces atherosclerosis are only partially understood. The effect of Hcy on T lymphocyte proliferation and its mechanisms were examined in normal and hyperhomocysteinemia ApoE-knockout mice. Methods: The mouse splenic T-cells were treated with Hcy, related compounds and / or antioxidants in the presence or absence of Concanavalin A (Con A). DNA synthesis, cell apoptosis, interleukin-2 level and production of reactive oxygen species (ROS) were measured. Results: Hcy (0.3-3.0 mM) and related compounds with thiol (-SH), such as cysteine and glutathione significantly potentiated Con A-induced proliferation and partially inhibited apoptosis in T lymphocytes, but it had no direct effect on resting T lymphocyte. ApoE-knockout mice with hyperhomocysteinemia (the level of plasma Hcy was 20.362.9 vs. 2.660.6 mM in control group, P,0.05) had a significant promotion of T-cell proliferation in response to Con A. Hcy (0.3-3.0 mM) also increased the intracellular ROS. Radical scavengers reduced Hcy effect. Conclusions: These data indicate that ROS generated by thiol (-SH) of Hcy auto-oxidation are involved in Hcy effect on Con A-induced T lymphocyte proliferation. These findings suggest a novel mechanism may be involved in chronic inflammatory progression of atherosclerosis with hyperhomocysteinemia.
Introduction
al dysfunction [3] and promotes the proliferation of vascular smooth muscle cells [4] . Substantial evidence Homocysteine (Hcy) is the sulfur-containing amino acid suggests that it involves cellular immune system in formed during the metabolism of methionine. Hyperatherogenesis. Atherosclerosis fulfills many criteria of a homocysteinemia has been found in 20-30% of patients chronic inflammatory process. It is recognized that T with premature atherosclerosis involving carotid, coronary lymphocytes accumulate in the lesions during the earlier and peripheral arteries [1] . Elevated plasma Hcy levels stages of atherosclerosis, perhaps even preceding monohave been defined as an independent risk factor for cytes. In the advanced atherosclerotic plaque, T lymphocoronary heart disease [2] . Yet the mechanism by which cytes represent up to 20% of the cells, 10% of which are in homocysteinemia induces atherosclerosis is still unclear.
an activated state [5] . However, the effects of Hcy on T Recent studies demonstrate that Hcy enhances endothelilymphocyte function have not been investigated in normal and ApoE-knockout mouse with elevated Hcy. The thiol (-SH) group of Hcy is readily oxidized and Health Science Center, Peking University, 38 Xue Yuan Road, Beijing peroxide (H O ) and hydroxyl radical (OH ) are generated 2 2 100083, PR China. Tel.: 186-10-6209-1443; fax: 186-10-6201-7700. [6] . These oxygen-derived molecules are believed to vascular smooth muscle cell proliferation [3, 7] . Recently, 2.3. T-cell proliferation assay it has been reported that the increase of reactive oxygen 3 species (ROS) following various external stimuli at low Cell proliferation was determined by [ H]thymidine concentration may function as cellular signaling interincorporation, an index of DNA synthesis. Cells were mediators and be associated with cellular proliferation [8] .
plated in triplicate samples in flat bottomed 96-well culture 5 Therefore, we hypothesized that there might be a relationplates at a density of 2310 cells / well in RPMI-1640 ship between Hcy stimulation, T lymphocyte proliferation medium containing 5% fetal calf serum. Cultures were and ROS production. The present study suggests that the treated for 72 h with Hcy (0.1-10 mM) in the presence or ROS generated by thiol (-SH) auto-oxidation of Hcy absence of 2 or 4 mg / ml Con A, or with related commight function as second messenger to promote Con Apounds including homoserine, homocystine, cysteine, induced proliferation in cultured mouse splenic T lymphoglutathione and methione, or 30-min pretreatment with cytes. The T-cell proliferation in response to Con A in antioxidants including catalase, superoxide dismutase ApoE-knockout mice with hyperhomocysteinemia is great-(SOD), glutathione peroxidase (GPX) and 1% DMSO 3 ly increased. The hyperhomocysteinemia might enhance before exposure to Hcy.
[ H]Thymidine (0.2 mCi / well) chronic inflammatory progression of atherosclerosis in was added during the last 6 h. The final total volume per concert with other stimuli. well was 0.2 ml. The cells were then harvested onto glass fiber filters. After drying under 80 8C for 2 h, the radioactivity was determined by liquid scintillation counting (Beckman, USA) and presented as counts per minute.
Methods
The data are expressed as the means6S.E.M. of the percentage of proliferation as compared to control group. 2.1. Animals
Measurement of plasma Hcy levels by EIA
The treatment of the laboratory animals and experimental protocols of the present study adhered to the guidelines Immediately following removal of blood of the ApoEof Peking University and were approved by the Institutionknockout mice with or without a diet of methionine, the al Authority for Laboratory Animal Care. All experiments samples were placed in EDTA-containing test tubes. were carried out in healthy, male Balb / C mice (6-8 weeks Following centrifugation the plasma fractions were transold, 18-22 g). Animals were obtained from the animal ferred to other polypropylene tubes and stored at 220 8C laboratory of the Health Science Center of Peking Unifor not more than 2 months before analysis for Hcy levels versity. They were housed in wire-mesh cages at 22 8C
by Hcy EIA reagent kit (Bio-Rad, CA, USA). ambient temperature and maintained on food and water ad libitum with a 12-h light / 12-h dark cycle for 1-2 weeks 2.5. IL-2 assay prior to all experiments. The ApoE-knockout mice were fed with a diet of methionine (400 mg / kg per day) for 6 T-cells were incubated with Con A (2 mg / ml) and Hcy weeks by which the hyperhomocysteinemia was induced as (1.0 mM) for different time periods. The culture superpreviously reported [9] . natants were harvested and the interleukin-2 (IL-2) level was measured using an ELISA assay kit (Genzyme, Cambridge, MA). The assay was performed according to 2.2. Preparation of T lymphocytes the manufacturer's instructions.
Cells were obtained from spleen of male Balb / C mouse by techniques previously described [10] . T lymphocytes 2.6. Flow cytometric analysis were purified by negative selection as described [11] . 6 Briefly, single cell suspensions of spleen was centrifuged.
Cells (3310 ) were incubated with various concenAfter lysis of red blood cells, single cell suspensions were trations of Hcy (0.1-10 mM) with or without Con A (2 incubated for 2 h at 37 8C to allow adherence of macromg / ml) for 60 h. The cells were collected and washed with phages. The non-adherent cells were collected and incu-PBS three times. Cells were incubated in the dark in a bated in Petri dishes coated with mouse anti-IgG for 1 h at solution containing 0.1% citrate, 0.1% Triton X-100 and room temperature. The non-antibody-conjugated cells (T propidium iodide (PI) 50 mg / ml before measurement. The lymphocytes) were collected RPMI-1640 medium at 37 8C.
488-nm line of an argon laser provided excitation of PI. The purity of the T-cells was shown to be 85% determined
The red fluorescence of PI was analyzed on a FACScan tion. After excluding cellular debris, the hypodiploid signals were determined as apoptotic cells. A total of analyzed using one-way ANOVA and further analyzed 10 000 measurements were conducted per experiment.
using the Student's-Newman-Keuls test for multiple comparisons between treatment groups. A P-value of 2.7. TUNEL assay ,0.05 indicates significant differences between treatment group means.
6 Cells (1.0310 ) were incubated with various concentrations of Hcy (0.1-10 mM) with or without Con A (2 or 4 mg / ml) for 60 h. Cells were then fixed in 4% methanol-3. Results free formaldehyde, permeabilized with 0.2% Triton X-100 in PBS, and labeled with fluorescein-tagged deoxyuridine 3.1. Effects of Hcy on Con A-induced T lymphocyte triphosphate (dUTP) by the terminal deoxynudeotidyl proliferation transferase-mediated dUTP nick-end labeling (TUNEL) method according to TUNEL kits (Promega, Madison,
To test whether Hcy affected T lymphocyte prolifer-WI). To quantify an apoptotic event, the percentage of ation, cells were cultured in 5% FBS RPMI-1640 with Hcy TUNEL-positive cells to total cell population was calcuin the presence or absence of Con A 2 mg / ml for 72 h. As lated by counting all cells from five random microscopic shown in Fig. 1A , Hcy (0.3-1.0 mM) caused a significant fields at a magnification of 3100.
Measurement of intracellular ROS generation
Hcy (0.1-10 mM) was added to the cells together with 29,79-dichlorofluorescin diacetate (DCFH-DA) 15 mM for 25 min. The determination of intracellular oxidant production was based on the oxidation of DCFH-DA by intracellular ROS, resulting in the formation of the fluorescent compound 29,79-dichlorofluorescin (DCF) [12] . DCF fluorescence was monitored with a confocal laser-scanning microscope (Leica, Germany).
Measurement of LDH release
T lymphocytes were treated with Hcy (0.1-10 mM) in the presence of Con A (2 mg / ml) for 72 h. Cell suspensions were collected for determination of LDH and LDH activity was measured by spectrophotometric enzyme activity method [13] . LDH activity was expressed as units per liter medium.
Chemicals
glutathione (reduced form), GPX and Con A were purchased from Sigma (St. Louis, MO). 29,79-Dichlorofluorecin diacetate was purchased from Molecular Probes (Eugene, OR). RPMI-1640 was purchased from Gibco (Grand island, NY). Mouse IL-2 ELISA kit was purchased from Genzyme (Cambridge, MA). TUNEL kit was purchased from Promega (Madison, WI). Catalase, SOD and other chemicals were purchased from Chinese Chemical, Beijing, China. potentiation of Con A-induced proliferation in T lympho-3 cytes. Compared to Con A 2-mg / ml-induced [ H]TdR incorporation, it caused increases of 1204 and 2574%, respectively, and compared to Con A 4-mg / ml-induced 3 [ H]TdR incorporation, increases of 1732 and 3361%, respectively. Hcy at 1.0 mM caused a maximum of T-cell proliferation in these cells. When the concentration of Hcy was in excess of 3.0 mM, potentiating effects of Hcy declined (Fig. 1A) . In addition, Hcy (0.1-10 mM) had no direct effect on resting T lymphocyte proliferation (Fig.  1B) .
Effect of Hcy on Con A-induced T lymphocyte apoptosis
To determine whether the increase of Con A-induced T lymphocyte proliferation by Hcy was produced by inhibiting its apoptosis, we tested cells after 24, 48, 60 and 72 h of stimulation for the presence of apoptotic cells and found that 60-h exposure to Hcy 1.0 mM began to significantly inhibit Con A-induced T lymphocyte apoptosis (data not shown). T-cells were then cultured with Hcy (0.3-10 mM) for 60 h in the presence or absence of Con A. As seen in Fig. 2A , Hcy (0.3-1.0 mM) could inhibit Con A-induced T lymphocyte apoptosis from 48.5 to 37.8 and 36.1%, respectively, as observed by flow cytometry. However, when the concentration of Hcy exceeded 3.0 mM, it could not further inhibit the Con A-induced apoptosis in the T lymphocytes. The Hcy had no direct effect on resting T lymphocyte apoptosis (data not shown). Hcy (0.3-1.0 mM) could also inhibit Con A 2-mg / ml-induced TUNELpositive cells from 36.1 to 26.3 and to 20.9%, respectively. However, increasing the concentration of Hcy to 3.0 and 10 mM could not further inhibit the Con A-induced TUNEL-positive cells (Fig. 2B) . The Hcy had no direct effect on resting T lymphocyte apoptosis (data not shown). To further investigate the effect of Hcy on T lymphocyte proliferation in vivo, hyperhomocysteinemia was induced after 6 weeks with a diet of methionine of 400 mg / kg per day. The level of plasma Hcy was 20.362.9 vs. 2.660. 6 3.4. Effect of Hcy on Con A-induced IL-2 production in mM in control group (P,0.05, n54). Splenic T lympho-T lymphocytes cytes were incubated in the presence of Con A (2 or 4 mg / ml) for 72 h. As shown in Fig. 3A , Con A-induced It is reported that the proliferation of T-cells in response proliferative response of T-cells obtained from ApoEto mitogens in vitro is largely dependent on the production knockout mice with hyperhomocysteinemia was greatly of IL-2 [14] . To test whether IL-2 was involved in the enhanced as compared with control (no methionine treatpotentiating effect of Hcy on Con A-induced T lymphocyte ment). In addition, Con A 4-mg / ml-, but not 2-mg / ml-, proliferation, the cells were incubated with Con A alone or induced apoptotic response of T-cells obtained from ApoEplus Hcy 1.0 mM, which potentiated the Con A-induced T knockout mice with hyperhomocysteinemia was signifilymphocyte proliferation to a maximum at different time cantly inhibited as compared with control with no points. Con A 2 mg / ml caused a time-dependent increase methionine treatment (Fig. 3B) .
of IL-2 production at 48, 60 and 72 h. However, at each Glutathione g-Glu-Cys-Gly 1 1, Capable of promoting Con A-induced T lymphocyte proliferation; 2, not capable of promoting Con A-induced T lymphocyte proliferation.
Con A-induced proliferation to 778.36127.3, 201.3639.9 and 181632.7%, respectively. In comparison with D,Lcysteine and glutathione, D,L-Hcy was three to four times more potent. However, other compounds without thiol (-SH) had no effects at all on Con A-induced proliferation in T lymphocytes.
Effect of Hcy on intracellular ROS levels
To determine whether Hcy induced more ROS production in Con A-stimulated T lymphocytes, we measured the ROS level using the redox sensitive fluorescent dye DCFH-DA, a process that has been demonstrated to depend on the intracellular production of ROS [15] . Our data demonstrated that the peak fluorescence intensity To test further the role of oxygen radicals in Con Aand / or Hcy-induced proliferation, cells were pretreated for time point, Hcy 1.0 mM could not further increase Con 30 min with antioxidants such as catalase 250 mg/ml (a A-induced IL-2 levels (data not shown).
scavenger of H O ), GPX 0.1 U / ml (a scavenger of .4%, methionine, were added to Con A 2 mg / ml for 72 h. As respectively. However, these antioxidants had no inhibitory shown in Table 1 , the compounds with thiol (-SH), such effects on Con A alone-induced T lymphocyte proliferas D,L-Hcy, D,L-cysteine and glutathione, all potentiated ation.
Discussion
This study shows for the first time that Hcy potentiated Con A-induced proliferation and inhibited cellular apoptosis in mouse spleen T lymphocytes. ApoE-knockout mice with hyperhomocysteinemia had an enhanced susceptibility of mitogen-induced T lymphocyte proliferation comparing to control group. Related compounds with thiol (-SH), such as cysteine and glutathione, also promoted mitogen-induced T lymphocyte proliferation. Hcy increased the production of ROS from T lymphocytes. The potentiating effect of Hcy on Con A-induced T lymphocyte proliferation was significantly reduced by antioxidants. However, IL-2 was not involved in the action of Hcy. These data suggest that ROS generated by thiol (-SH) auto-oxidation is involved in T lymphocyte proliferation induced by Hcy. Hyperhomocysteinemia may be involved in the pathogenesis of atherosclerosis by enhancing T-cell have focused on injury of endothelial cells and proliferation of vascular smooth muscle cells induced by Hcy [3, 4] . In the advanced atherosclerotic plaque, T lympho-3.8.
Effect of Hcy on LDH release from Con A-
cytes represent up to 20% of the cells, and |10% of the activated T lymphocytes T-cells show signs of activation [5, 16] . The occurrence of antigen-driven T-cell proliferation in atherosclerotic leTo determine the effect of Hcy on LDH release, the sions of ApoE-deficient mice was also reported [17] [18] [19] . lymphocytes were incubated with Con A and / or Hcy at a
The present study showed that Hcy at 0.1 mM as threshold concentration of 0.1-10 mM for 72 h. Hcy (3.0-10 mM) concentration potentiated Con A-induced proliferation, but significantly caused a concentration-related increase in it had no direct effect on resting T lymphocyte prolifer-LDH release as compared with Con A alone (data not ation. In addition, we demonstrated that ApoE-knockout shown).
mice with hyperhomocysteinemia significantly increased Fig. 5 . Inhibitory effect of antioxidants on Hcy-induced proliferation in T lymphocytes. Cells were pretreated with antioxidants, catalase (Cata, 250 mg / ml), GPX 0.1 U / ml, SOD 500 U / ml or 1% DMSO for 30 min, and then stimulated by Hcy 1.0 mM in the presence of Con A for 72 h. Cell susceptibility of T-cell proliferation and apoptosis in the proliferation as previously reported [25] . These data sugpresence of Con A. Therefore, these results suggest that gest that the production of intracellular ROS induced by Hcy acts only as a modulator to promote mitogen-induced thiol (-SH) auto-oxidation is involved in the effect of proliferation in T lymphocytes.
Hcy-induced T lymphocyte proliferation. [20, 21] . Our results showed that elevated Hcy (0.3-1.0 reported that Hcy-induced damage to the vascular endomM), which potentiated Con A-induced T lymphocyte thelium and the promotion of vascular smooth muscle cell proliferation, could partially inhibit its apoptosis both in proliferation are secondary to oxygen radicals generated by vitro and in vivo. This suggests that the potentiating effect oxidation of the thiol (-SH) group of Hcy [7, 26] . of Hcy on Con A-induced T lymphocyte proliferation may IL-2 is a major growth factor of activated T lymphobe mediated in part through inhibition of cellular apopcytes during a developing immune response. We found that tosis. However, additional mechanisms may also be inCon A at a concentration of 2 mg / ml caused time-depenvolved in Hcy-induced T lymphocyte proliferation since dent IL-2 production, which is consistent with the report of Hcy enhances proliferation more than it inhibits apoptosis other groups [27] . However, at each time point, Hcy could in these cells.
not further increase Con A-induced IL-2 production. These It is reported that thiol (-SH) is involved in regulation data suggest that IL-2 is not involved in Hcy-potentiated T of lymphocyte proliferation [22] . The present study demlymphocyte proliferation. onstrated that compounds related to thiol (-SH), such as Atherosclerosis appears to be associated with Hcy cysteine and glutathione, could promote Con A-induced concentrations of 0.2-0.25 mM and plasma concentrations proliferation in T lymphocytes, while other compounds up to 0.5 mM have been found in patients suffering from without thiol (-SH) had no such effects. This suggests that homocysteinuria [2] . In the present study, Hcy significantly thiol (-SH) plays a key role in the action of Hcy. In increased Con A-induced T lymphocyte proliferation at 0.3 addition, we observed that the effect of Hcy was the mM as threshold concentration, which is similar to those strongest, compared with cysteine and glutathione. This observed in clinical patients. In local plaque, the condifference might be due to its chemical property. The centration of Hcy is still unknown; it may be higher than ammonium group of cysteine (HSCH CHNH COOH) that of plasma. In atherosclerotic plaque, the activation of because it has one more methylene group than cysteine, the the progression of lesions, including oxLDL uptake, withdrawing effect of ammonium group on the thiol group adhesion molecule expression and smooth muscle proliferwill be weaker. Therefore, the thiol of Hcy is more active ation [29, 30] . Our results suggest that Hcy may promote and can be more easily auto-oxidated than that of cysteine.
the function of activated T lymphocyte as a modulator and There is now growing evidence that ROS at low enhance susceptibility in T lymphocyte of ApoE-knockout concentrations play some physiological roles including mice, an animal model of atherosclerosis. The exact effect activation and proliferation of lymphocytes [23, 24] . To of Hcy on activated T lymphocyte in plaque of atheroclarify the mechanism that ROS act as a mediator in the sclerosis in vivo is not yet known. The role of hyperCon A-activated T lymphocytes proliferation potentiated homocysteinemia in animals and patients with atheroby Hcy, we first assessed the production of intracellular sclerosis is currently being investigated in our laboratory. ROS using the redox sensitive fluorescent dye DCFH-DA.
In conclusion, we demonstrated that Hcy significantly We found that 0.3-3.0 mM Hcy, the concentration which potentiated activated T lymphocyte proliferation by partialpotentiated Con A-induced T lymphocyte proliferation, ly inhibiting its apoptosis in mouse splenic T lymphocytes. could increase the intracellular oxidation of DCFH, the ApoE-knockout mice with hyperhomocysteinemia showed latter being produced equally by the intracellular superoxa significant enhancement of T lymphocyte proliferation in [12] . However, when the concentration of Hcy oxidative products are involved in the action of Hcy. 2 2 exceeded 3.0 mM, it could not further increase the level of Elucidation of Hcy effect on T lymphocyte function might intracellular ROS. This might be due to its toxic injury of be helpful to explain the mechanism of hypercells as determined by LDH release. In addition, the homocysteinemia patients with atherosclerosis. potentiating effect was prevented by pretreatment with different antioxidants that are well known as radical scavengers. For example, SOD catalyses the dismutation ofcells: the protective effect is mediated by an adenosine A receptor Center, Peking University for their helpful suggestions. 
